First | Latest Filing | SEC File | | Act: | | Filings [ re: Other Registrants ] |
---|
| | | | Other Issuer | | | | (newest to oldest Filing Type) |
|
| | 3/25/24 | | 333-278205-01 GSK plc | | ’33: | | F-3ASR [ by Glaxosmithkline Capital Inc. ] |
5/4/12 | | 10/2/23 | | 001-35541 | | ’34: | | 25-NSE, 6-K, CERT, 8-A12B, 11-K, CERTNYS [ re: Show 3 ][ re: Hide 3: New York Stock Exchange LLC GSK plc Glaxosmithkline Capital Inc. ] |
3/26/21 | | 3/16/23 | | 333-254756-01 GSK plc | | ’33: | | EFFECT, POS AM, F-3ASR [ by Glaxosmithkline Capital Inc. ] |
3/28/18 | | 9/30/20 | | 333-223982-02 GSK plc | | ’33: | | 424B2, F-3ASR [ by Glaxosmithkline Capital Inc. ] |
| ’34: | | FWP |
4/3/17 | | 4/19/17 | | 333-217125-02 GSK plc | | ’33: | | EFFECT, F-3 [ by Glaxosmithkline Capital Inc. ] |
3/21/14 | | 10/4/16 | | 333-194744-01 GSK plc | | ’33: | | EFFECT, POS AM, F-3ASR [ by Glaxosmithkline Capital Inc. ] |
3/4/11 | | 5/4/12 | | 333-172621-01 | | ’33: | | 424B2, F-3ASR [ re: Show 2 ][ re: Hide 2: GSK plc Glaxosmithkline Capital Inc. ] |
| ’34: | | FWP
|
3/4/08 | | 5/2/12 | | 333-149531-01 GSK plc | | ’33: | | F-3ASR [ by Glaxosmithkline Capital Inc. ] |
| ’34: | | 6-K |
3/28/03 | | 4/7/04 | | 333-104121-01 GSK plc | | ’33: | | 424B2, F-3/A, F-3 [ by Glaxosmithkline Capital Inc. ] |
| ’34: | | 6-K |